Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

313.88 +1.72 (+0.55%)
Streaming Delayed Price Updated: 1:50 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
These Stocks Jumped 100% and 30% Last Year. Here's Why They're Still a Buy.
These stocks look cheap if you take a long-term view. 
Via The Motley Fool
3 Biotech Companies to Watch in 2023
These biotech companies to watch are remarkably strong businesses that offer healthy upside potential as we head into a new year. 
Via InvestorPlace
2 Under-the-Radar Biotech Stocks to Buy in 2023
These biotechnology stocks are pushing ahead with promising innovations. 
Via The Motley Fool
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too. 
Via Investor's Business Daily
Vertex to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 9
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 Must-Have Stocks to Buy in 2023
There's too much to like with these stocks to pass them by. 
Via The Motley Fool
Where to Invest $100,000 in 2023
The holidays are over. Let's put our money to work. 
Via The Motley Fool
10 Top Stocks That Can Make You Richer in 2023
A new year brings new opportunities for investors to build their wealth on Wall Street. 
Via The Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
These healthcare companies look poised to continue their runs. 
Via The Motley Fool
3 Stocks to Buy for 2023 That Are Practically Money Machines
If money makes the world go round, these three stocks could have it really spinning. 
Via The Motley Fool
1 Cathie Wood Stock to Buy While It's Affordable, and 1 to Avoid (for Now)
Both stocks have fallen brutally this year, but only one has a chance to recover soon. 
Via The Motley Fool
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
These two biotechs are flying high right now. 
Via The Motley Fool
5 Unstoppable Trends to Invest $5,000 in for 2023
These trends won't fade away, and some of the companies that are positioned to ride them should be big winners. 
Via The Motley Fool
2 Top Stocks to Invest $2,000 in Before the End of 2022
The new year is almost upon us. 
Via The Motley Fool
Could CRISPR Therapeutics Help You Become a Millionaire?
The gene-editing stock still has plenty of promise. 
Via The Motley Fool
Is Vertex Pharmaceuticals a Buy?
There's more growth ahead for this biotech giant. 
Via The Motley Fool
Here Are the Best Stocks To Own as 2022 Draws to a Close
They have what it takes to deliver growth over time. 
Via The Motley Fool
After Doubling in the Past 6 Months, Is This Stock a Buy?
This company has had a solid year, but there is still plenty of work ahead. 
Via The Motley Fool
Crispr Stock In 2023: Will Down-In-The-Dumps Shares Sparkle Again In 2023?
Crispr and Vertex are working toward the first submissions for a CRISPR-based product. 
Via Investor's Business Daily
2 No-Brainer Biotech Stocks to Buy Right Now
Vertex Therapeutics and Amgen have the building blocks for long-term success. 
Via The Motley Fool
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
It's always the right time to be planning for a better retirement. 
Via The Motley Fool
Here's Why the Bear Market Could End in 2023
Now could be the opportune time to load up on some quality growth stocks. 
Via The Motley Fool
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
For many investors, now would be an opportune time to take advantage of great stocks trading at a discount. 
Via The Motley Fool
3 Growth Stocks That Are Too Cheap to Ignore
Growth stocks are down, but these companies are far from out of the game. 
Via The Motley Fool
3 Growth Stocks That Are Screaming Buys in December
Don't let these companies pass you by the next time you go stock shopping. 
Via The Motley Fool
The Best Stocks to Invest $20,000 in Right Now
The investments you make now could power your portfolio returns for years to come. 
Via The Motley Fool
Tuesday Talk: Where is Santa?
Monday continued the downtrend for the major indices on Wall Street which concluded a second week of losses on Friday. As for an annual Santa rally, that seems nowhere to be found. 
Via Talk Markets
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro
The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
 
Via Benzinga
Where Will Vertex Pharmaceuticals Be in 10 Years?
Expect a bigger, more diversified, and more entrenched entity to emerge over the coming years. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.